Latest Stock Market News

Marksans Pharma, incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 4524.84 Crore) operating in Pharmaceuticals sector.

The stock quoted a 52-week high of Rs 1828.75 and a 52-week low of Rs 1147.05.

“I do not think we will grow without adding any headcount. There will be some addition of headcount to support the growth because the ask rate for the next three quarters are quite high. So, there will be headcount addition,” says HCLTech CEO &B MD C Vijayakumar.

A total of 184,028 shares changed hands on the counter till time (IST).

The second is if you take on a four-five-year basis, the valuations are not necessarily cheap, they have corrected a lot in the last one, one-and-a-half-year but it had been one of the best performing sector from 2017 to 2020.

The valuation premium for stocks in the South Asian nation has risen sharply against that of emerging market, Asian and global peers. “In the short-term, the market has got stretched, so a 3-5% correction is on the cards,” said Atul Suri, a fund manager at Marathon Trends Advisory Pvt Ltd.

Morgan Stanley maintained an overweight rating on IndusInd Bank with a target price of Rs 1725. The global investment bank believes that the share price will rise relative to the industry over the next 30 days.

The tech-enabled platform is also setting up a feeder fund--the Global Investors Feeder Trust (GIFT)--based out of GIFT City to cater to foreign investors.

​And if that is the scenario, obviously whatever Fed does, it kind of flows across the world so I think globally interest rates will be lower, one to two years lower.

The aggregate profit of Nifty 50 companies are likely to rise 25% on year in the June quarter, but if metals and oil and gas sectors are excluded, the growth is likely to have been as high as 40%, according to Motilal Oswal Securities.